8-KThe WireRoutine
Company Update
Filed Jan 5, 2026 · 5mo ago · Accession 0001193125-26-001472
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- 8-K
- Filing date
- Jan 5, 2026
- Report date
- Jan 5, 2026
- Document
- d33765d8k.htm
- Size
- 192 KB